The development of treatment guidelines for illnesses such as diabetes is a complicated process. The New York Times reports: “The goal [of creating guidelines] is to improve treatment and, at the same time, save money. But setting guidelines that are good for every patient… can get messy, with some experts warning that a big national plan of this sort poses risks.
A Quick And Accurate Way Of Diagnosing Endometriosis
A quick and accurate test for endometriosis that does not require surgery has been developed by researchers from Australia, Jordan and Belgium, according to new research published online (Wednesday 19 August) in Europe’s leading reproductive medicine journal Human Reproduction [1].
New Way To Clinically Assess Condition Of Tooth Enamel Using Lasers Described By Optics Express Paper
A group of researchers in Australia and Taiwan has developed a new way to analyze the health of human teeth using lasers. As described in the latest issue of Optics Express, the Optical Society’s (OSA) open-access journal, by measuring how the surface of a tooth responds to laser-generated ultrasound, they can evaluate the mineral content of tooth enamel — the semi-translucent outer layer of a tooth that protects the underlying dentin.
Work On Diagnostic, Intervention Tools For H1N1 In Swine Helps Human Health Lab, Too
If some day you are tested for the H1N1 virus without the painful prick of a needle, thank a pig — and a team of Kansas State University researchers and their collaborators who are connecting animal and human health. K-State professors Dick Hesse and Bob Rowland — along with a research partner at Iowa State University — are collaborating with Susan Wong, a scientist at the New York State Department of Health, on diagnostic and intervention tools for the H1N1 virus.
US HIFU Announces Addition Of Tissue Change Monitoring (TCM) Software To Sonablate(R) 500 Medical Device
US HIFU, LLC, introduces a new software component, called Tissue Change Monitoring (TCM), to its Sonablate(R) 500 medical device that will enhance its existing minimally invasive treatment for prostate cancer using HIFU, high intensity focused ultrasound, by enabling physicians to monitor prostatic tissue changes in real-time. Stephen Puckett, Jr., chief executive officer, US HIFU said, “TCM represents yet another major step forward for the Sonablate(R) HIFU platform.
SyntheMed Receives Russian Regulatory Approval For REPEL-CV(TM)
SyntheMed, Inc. (OTC Bulletin Board: SYMD), a biomaterials company engaged in the development and commercialization of anti-adhesion products, announced that REPEL-CV, the company’s bioresorbable adhesion barrier film for the reduction of adhesions following cardiac surgery, has received approval from the Ministry of Health of the Russian Federation for use in all patients who undergo open heart surgery. REPEL-CV will be marketed throughout Russia by Cardiomedics, Ltd.
Clinical Study Proves Pollogen’s TriPollar(TM) Radio Frequency Technology Is Effective In The Treatment Of Stretch Marks
Pollogen’s TriPollar(TM) technology, the most advanced 3rd generation radio frequency solution for facial and body contouring, has been clinically proven to be effective in treating stretch marks or striae distensae. The peer reviewed paper entitled “Treatment of striae distensae with a TriPollar radiofrequency device: a pilot study” authored by Dr Manuskiatti et al, has been published in the Journal of Dermatological Treatment.
Carbon Nanomaterials For Drug Delivery Systems, Oxygen Sensors, Harnessed By Pitt Researchers
Two nanoscale devices recently reported by University of Pittsburgh researchers in two separate journals harness the potential of carbon nanomaterials to enhance technologies for drug or imaging agent delivery and energy storage systems, in one case, and, in the other, bolster the sensitivity of oxygen sensors essential in confined settings, from mines to spacecrafts. In a report published online by Advanced Materials Aug.
Labels Should Tell You How Drug Compares With Similar Treatments Say Researchers
Researchers from a leading US medical institution want the US Food and Drug Administration (FDA) to require drug companies to describe on the label how the new product compares with existing ones and suggest that in many cases they would reveal the new one was no better and this would make patients and insurers less likely to pay for newer treatments.
First HaloPure(R) Drinking Water Disinfection Device Registered By U.S. EPA
HaloSource®, a leading clean water and antimicrobial solutions company, has been granted United States Environmental Protection Agency device registration (EPA Reg. No. 72083-4) for the HaloPure® Water Purifier Insert, a demonstration product powered by its revolutionary HaloPure BR® technology. HaloPure BR provides safe, clean drinking water at the point of use in a variety of applications.
CMS announces catheter ablation coverage panel
Go directly to MassDevice. Having trouble reading this email? View this newsletter in your browser here.
Not interested? Unsubscribe.